- Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
New England Journal of Medicine, Ahead of Print. <br/>
- Personalized Gene Editing to Treat an Inborn Error of Metabolism
New England Journal of Medicine, Ahead of Print. <br/>
- Progress in the Development of N-of-1 Therapy
New England Journal of Medicine, Ahead of Print. <br/>
- Alternative Complement Pathway, Iptacopan, and IgA Nephropathy
New England Journal of Medicine, Volume 392, Issue 19, Page 1975-1976, May 15/22, 2025. <br/>
- Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
New England Journal of Medicine, Volume 392, Issue 19, Page 1941-1952, May 15/22, 2025. <br/>
- Longitudinal Changes in Airway Mucus Plugs and FEV1 in COPD
New England Journal of Medicine, Volume 392, Issue 19, Page 1973-1975, May 15/22, 2025. <br/>
- Xenotransplantation — Long Awaited, Much Learned, Much More to Be Learned
New England Journal of Medicine, Volume 392, Issue 19, Page 1971-1972, May 15/22, 2025. <br/>
- Second-Line Antiretroviral Therapy for Children Living with HIV in Africa
New England Journal of Medicine, Volume 392, Issue 19, Page 1917-1932, May 15/22, 2025. <br/>
- Plight on the Pickleball Court
New England Journal of Medicine, Volume 392, Issue 19, May 15/22, 2025. <br/>
- Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1
New England Journal of Medicine, Volume 392, Issue 19, Page 1905-1916, May 15/22, 2025. <br/>
- Case 14-2025: A 29-Year-Old Woman with Peritonsillar Swelling and Bleeding
New England Journal of Medicine, Volume 392, Issue 19, Page 1954-1964, May 15/22, 2025. <br/>
- Torsion of a Mature Cystic Ovarian Teratoma
New England Journal of Medicine, Volume 392, Issue 19, May 15/22, 2025. <br/>
- Hair Tourniquet
New England Journal of Medicine, Volume 392, Issue 19, May 15/22, 2025. <br/>
- Progress toward Mitigating Disability Progression in Multiple Sclerosis
New England Journal of Medicine, Volume 392, Issue 19, Page 1966-1968, May 15/22, 2025. <br/>
- Targeting Orexin Receptors to Treat Narcolepsy
New England Journal of Medicine, Volume 392, Issue 19, Page 1968-1971, May 15/22, 2025. <br/>
- Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries
New England Journal of Medicine, Ahead of Print. <br/>
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
New England Journal of Medicine, Ahead of Print. <br/>
- Sixty Years of Community Health Centers — An Anniversary at a Crossroads
New England Journal of Medicine, Volume 392, Issue 19, Page 1875-1877, May 15/22, 2025. <br/>
- AI-Driven Clinical Documentation — Driving Out the Chitchat?
New England Journal of Medicine, Volume 392, Issue 19, Page 1877-1879, May 15/22, 2025. <br/>
- Driving Jackson
New England Journal of Medicine, Volume 392, Issue 19, Page 1879-1881, May 15/22, 2025. <br/>
- Paget’s Disease of Bone
New England Journal of Medicine, Volume 392, Issue 19, Page 1953-1953, May 15/22, 2025. <br/>
- Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
New England Journal of Medicine, Ahead of Print. <br/>
- Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
New England Journal of Medicine, Ahead of Print. <br/>
- Judicial Invalidation of the FDA’s Laboratory-Developed Test Rule — Legal and Public Health Consequences
New England Journal of Medicine, Ahead of Print. <br/>
- U.S. Research Leadership at a Crossroads — The Impact of Reducing NIH Indirect-Cost Coverage
New England Journal of Medicine, Ahead of Print. <br/>